基本信息
浏览量:277
职业迁徙
个人简介
My laboratory concentrates on the development of new cancer treatments with an emphasis on the use of immunotherapy and monoclonal antibodies. We are capable of making new monoclonal antibodies against various cancer related targets and have recently received a patent for one such antibody. In collaboration with a number of other scientists at Fox Chase and as a result of laboratory based studies conducted here, I have developed clinical trials that are ongoing for treatment of patients with lung cancer.
My collaborations with scientists outside of Fox Chase also is an important part of what I do with the aim of bringing newer and more effective immune based treatments to the clinic. My laboratory also examines patients’ tumors to try to learn why some patients respond to specific treatment while others don’t. Discovery of new or better ways of treating cancer is an important part of my activities here.
In addition to laboratory based investigations, I am active in clinical trials. My goal is to offer my patients some of the best options that are available. I believe that clinical trials, when offered appropriately, can not only help us develop the next best treatment options but also allow my patients access to potentially new and promising drugs.
In addition I am actively involved in lung cancer screening and research involving potential preventative measures with the hope of detecting lung cancer early and preventing recurrences of this disease.
My collaborations with scientists outside of Fox Chase also is an important part of what I do with the aim of bringing newer and more effective immune based treatments to the clinic. My laboratory also examines patients’ tumors to try to learn why some patients respond to specific treatment while others don’t. Discovery of new or better ways of treating cancer is an important part of my activities here.
In addition to laboratory based investigations, I am active in clinical trials. My goal is to offer my patients some of the best options that are available. I believe that clinical trials, when offered appropriately, can not only help us develop the next best treatment options but also allow my patients access to potentially new and promising drugs.
In addition I am actively involved in lung cancer screening and research involving potential preventative measures with the hope of detecting lung cancer early and preventing recurrences of this disease.
研究兴趣
论文共 336 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Thoracic Oncologyno. 11 (2023): S635-S636
JACC: CARDIOONCOLOGYno. 4 (2023): 542-545
Brinda Gupta,Sharon Wu,Sai-Hong Ignatius Ou,Sourat Darabi, Kathryn Finch Mileham,Nishant Gandhi,Benjamin Adam Weinberg,Misako Nagasaka,Hossein Borghaei,Patrick C. Ma,Alex Patrick Farrell,George W. Sledge,
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)
引用0浏览0引用
0
0
Matthew Zibelman, Alexander W. MacFarlane IV, Kimberly Costello,Thomas McGowan,John O’Neill,Rutika Kokate,Hossein Borghaei,Crystal S. Denlinger,Efrat Dotan,Daniel M. Geynisman,Angela Jain,Lainie Martin,
Nature Communicationsno. 1 (2023): 1-11
JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S635-S636
引用0浏览0引用
0
0
The New England journal of medicine (2023)
引用0浏览0WOS引用
0
0
Hossein Borghaei,Saiama Naheed Waqar,Debora S. Bruno, Satoru Kitazono,Kazushige Wakuda, Alexander I. Spira, Jairo Olivares,Gabriel Mak, Susan Lovick, Louise Goodwin,Kyriakos P. Papadopoulos
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): TPS3158-TPS3158
引用0浏览0引用
0
0
Cancer Epidemiology, Biomarkers & Preventionno. 1 (2023): 113-113
Luis E. Raez,Yasmine Baca, Carlos Carracedo,Ari Vanderwalde,Chadi Nabhan,Misako Nagasaka,Jorge Nieva, Hirva Mandani,Hossein Borghaei,Mark Socinski,Hina Khan,Antoinette Wozniak,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn